Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CEFTAZIDIME — all Canadian products

12 DINs
3 marketed/approved
0 in shortage

Every Health Canada Drug Identification Number whose active ingredient is CEFTAZIDIME, with holder, form, strength and current status, compared weekly against the Drug Product Database.

DINProductCompanyFormRouteStrengthStatusShortage
00886963CEFTAZIDIME FOR INJECTION, USPFRESENIUS KABI CANADA LTDPowder For SolutionIntravenousCEFTAZIDIME 6 GMarketed
00886971CEFTAZIDIME FOR INJECTION, USPFRESENIUS KABI CANADA LTDPowder For SolutionIntravenous; IntramuscularCEFTAZIDIME 1 GMarketed
00886955CEFTAZIDIME FOR INJECTION, USPFRESENIUS KABI CANADA LTDPowder For SolutionIntravenousCEFTAZIDIME 2 GMarketed
01968092CEPTAZ INJ 10GM/VIALGLAXO CANADA INCPowder For SolutionIntravenousCEFTAZIDIME 10 GCancelled Post Market
01974408CEPTAZ INJ 1GM/VIALGLAXO CANADA INCPowder For SolutionIntramuscular; IntravenousCEFTAZIDIME 1 GCancelled Post Market
01974416CEPTAZ INJ 2GM/VIALGLAXO CANADA INCPowder For SolutionIntravenousCEFTAZIDIME 2 GCancelled Post Market
02215012CEPTAZ INJECTION - PWS IM IV 1G/VIALGLAXOSMITHKLINE INCPowder For SolutionIntravenous; IntramuscularCEFTAZIDIME 1 GCancelled Post Market
02215020CEPTAZ INJECTION - PWS IV 2GM/VIALGLAXOSMITHKLINE INCPowder For SolutionIntravenousCEFTAZIDIME 2 GCancelled Post Market
02213737CEPTAZ INJECTION - PWS IV 10GM/VIALGLAXOSMITHKLINE INCPowder For SolutionIntravenousCEFTAZIDIME 10 GCancelled Post Market
00887129TAZIDIME ADD-VANTAGE INJ 1.0GM/VIALELI LILLY CANADA INCPowder For SolutionIntravenousCEFTAZIDIME 1 GCancelled Post Market
01980645TAZIDIME ADD-VANTAGE INJ 2GM/VIALELI LILLY CANADA INCPowder For SolutionIntravenousCEFTAZIDIME 2 GCancelled Post Market
00888338TAZIDIME INJ 500MG/VIALELI LILLY CANADA INCPowderIntravenous; IntramuscularCEFTAZIDIME 500 MGCancelled Post Market
Request a quote for CEFTAZIDIME

Browse other molecules:

ABCDEFGHIJKLMNOPQRSTUVWXYZ